市場調査レポート

商品コード

皮内注射市場の2028年までの予測-方法、アプリケーション、エンドユーザー別の世界分析

Intradermal injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method, Application, and End User

出版日: 2022年08月22日 | 発行: The Insight Partners

| ページ情報: 英文 197 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 713,258円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,026,778円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,340,298円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

皮内注射市場は、2021年の35億1326万米ドルから2028年には74億1570万米ドルに達すると予測され、2021年から2028年までのCAGRは11.3％と予測されています。

本レポートでは、市場に蔓延する動向と市場成長を促進する要因について取り上げています。皮内注射市場の成長は、皮内ワクチン接種の増加、さまざまな疾患の発生率の増加、美容処置の受け入れの高まりに起因しています。さらに、メーカーによるストラテジックな開発が、予測期間中に市場の重要な動向として現れると思われます。しかし、皮内注射に伴うリスク、合併症、投与量の制限などが、皮内注射市場の成長を妨げています。

発展途上国や先進国の多くは、現在、ヘルスケア部門を重要なセグメントの一つとして考えており、より良いインフラや医療施設を提供することを目的とした医療費の急激な増加をもたらしました。世界の需要の高まりに対応するため、さまざまな製薬会社が理想的な医薬品や機器の開発に取り組んでおり、皮内注射は治療、診断、ワクチン接種、美容整形などに使われる潜在的な機器の1つとして浮上しています。皮内接種の受け入れが増加していることは、従来の接種方法に比べていくつかの利点があるため、世界の皮内注射市場の主要な推進要因として作用すると考えられています。皮内接種では、抗原の潜在的な投与量を減らし、ワクチンによって生成される免疫反応を向上させ、ワクチン接種に関連する不安を減少させるのに役立ちます。皮内接種の開発により、比較的少ないワクチン製造量で多くの人々にワクチン接種を行うことができ、また、従来のワクチン接種と比較して有害事象の可能性が低く、合併症のある難しい人々へのワクチン接種も可能です。近年、COVID19、A型肝炎ワクチン、B型肝炎ワクチン、インフルエンザワクチン、ポリオワクチン、麻疹ワクチン、狂犬病ワクチン、破傷風ワクチン、黄熱病ワクチン、ジフテリア・破傷風・百日咳ワクチンなどの皮内投与型ワクチンが全体的に奏功率を向上させたため、複数の大手医薬品・バイオテクノロジー企業が市販ワクチンと同様に新しい皮内投与の開発にも取り組んでいるところです。2020年、サノフィは、インフルエンザ名Fluzoneの皮内注射ワクチンのFDA承認を受け、急速にインフルエンザワクチン市場を追い越し、これらの疾患の先天性治療に取って代わろうとしています。

また、世界人口の3分の1以上が結核を発症するリスクを抱えており、過去数年間、結核の皮膚テスト実施件数の激しい増加が観察されています。結核の診断には皮内用ツベルクリン注射器が使用され、現在、ドラッグデリバリー機器の大手メーカー数社がこのツベルクリン注射器を開発しています。これとともに、アレルギーの有病率は過去10年間で数倍に増加しています。これは主に、いくつかのアレルギー関連疾患に対する国民の意識が高まっていることが原因です。皮内注射は、いくつかのアレルゲンに対する感受性試験を行うための理想的なデバイスとして使用されています。

これに加えて、局所美容処置も急速に増加しており、ISAPSの推計によると、非外科的美容処置の数は2011年から2017年にかけて51.4%増加しているとのことです。これとともに、皮内接種が必要量や有害事象の低減とともにより良い反応を得ることができるため、多くの新しい皮内接種が承認を受けると考えられています。.また、皮内投与は、がん治療薬や免疫学的製剤の吸収を向上させ、遺伝子治療薬の投与にも使用できるとする研究結果も発表されています。さらに、COVID19の症例が継続的に増加していることも、この分野の将来的な可能性を示しています。世界の人口増加に伴い、近い将来、患者数は増加し、皮内注射の需要も増加するものと思われます。また、ファーマジェットのTropis IDのような新しい皮内投与デバイスは、様々な疾患をターゲットにした薬剤の投与に優れた効果を発揮し、皮内投与製品の治療領域を拡大しています。

皮内注射の利点に加えて、注射部位反応や投与量の制限など、これらのドラッグデリバリー機器にはいくつかの欠点もあり、これが皮内注射市場の主な抑制要因となっています。有効成分を皮内投与した後、注射部位に皮膚の変色、腫脹、発赤、かゆみ、炎症が起こることが確認されています。注射部位の感染に関する課題を克服するため、研究者は薬剤の性質や必要な作用に応じて、薬剤を注射するための理想的な部位を特定するために取り組んでいます。

過去数年間、皮内注射に関連する手順や機器は絶え間ない技術革新を受けており、この分野の発展のためにいくつかの新しい技術が取り入れられています。いくつかの合併症に関連するワクチン接種と診断率は、過去10年間に指数関数的に増加し、最終的に皮内注射の受け入れを増加させています。

皮内注射市場では、いくつかの有機的および無機的な戦略が企業によって採用されています。有機的戦略には、主に製品の上市と製品承認が含まれます。さらに、皮内注射市場で示された無機的な成長戦略は、買収、コラボレーション、およびパートナーシップです。これらの成長戦略は、市場参加者が事業を拡大し、地理的プレゼンスを増強することを可能にし、それによって皮内注射市場の全体的な成長に貢献します。さらに、買収とパートナーシップ戦略は、市場プレーヤーが顧客基盤を強化し、製品ポートフォリオを拡大するのに役立ちます。皮内注射市場の主なプレイヤーによる注目すべき発展のいくつかを以下に示します。

2021年11月、NanoPass TechnologiesとAesthetic Management Partnersは、NanoPassの皮内投与デバイスMicronJet 600の米国での商業化を開始する契約を締結しました。

2021年8月、PharmaJet社とZydus Cadila社は、世界初のCOVID-19用プラスミドDNAワクチンZyCoV-Dについて、インド医薬品監督庁（DCGI）から緊急使用承認（EUA）を取得しました。ZyCoV-Dは、PharmaJet Tropisニードルフリー注射システムを用いて単独で投与されるワクチンです。

皮内注射市場に関する報告書の作成にあたり、世界保健機関（WHO）、疾病管理予防センター（CDC）、国民健康保険などを一次情報および二次情報として参照しています。

主な市場促進要因
- 皮内接種の増加
- 疾病の発生率の増加
- 美容施術の受け入れの増加
主な市場抑制要因
- 皮内注射に関連するリスク、合併症、投与量の制限
主な市場機会
- 先進国および発展途上国での大きな成長機会
今後の動向
- メーカー別戦略的開発
推進要因と抑制要因の影響分析

第6章皮内注射の世界市場-分析

皮内注射の世界市場収益と予測・分析
皮内注射の世界市場：地域別予測・分析
主要プレイヤーの市場ポジショニング

第7章：皮内注射の世界市場収益と2028年までの予測-方法別

皮内注射の世界市場、方法別、2021年・2028年（%）
通常サイズの針（MANTOUX）
ショートニードル
ニードルなし

第8章皮内注射の世界市場収益と2028年までの予測- アプリケーション編

皮内注射の世界市場アプリケーション別シェア-2021年・2028年（%）
ツベルクリン皮膚反応
アレルギー検査
局所美容
その他
- その他市場の展望と分析

第9章皮内注射の市場分析～エンドユーザー編

皮内注射の世界市場：エンドユーザー別、2021年・2028年（%）
病院
診断ラボラトリー
学術・研究機関
その他

第10章皮内注射市場の収益と2028年までの予測-地域別分析

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- 韓国
- オーストラリア
- その他アジア太平洋地域
中東・アフリカ地域
- UAE
- サウジアラビア
- 南アフリカ
- その他の中東・アフリカ地域
中南米地域
- 中南米地域
  - アルゼンチン
  - ブラジル
  - その他の中南米地域

第11章 COVID-19パンデミックが皮内注射市場に与える影響

北米
欧州
アジア太平洋地域
中東とアフリカ
中南米

第12章皮内注射の市場-業界情勢

市場概要
開発状況

第13章企業プロファイル

BD
West Pharmaceutical Services, Inc.
Terumo Corporation
NanoPass
Pharmajet
Idevax
EUNSUNG GLOBAL
Crossject
Cardinal Health Inc.
Hindustan Syringes and Medical Devices Ltd

第14章付録

The Insight Partners について
用語解説

図表

List Of Tables

Table 1. North America Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Intradermal Injections Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 6. US Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 7. US: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 8. US: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 9. US Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 10. US Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 33. France: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 34. France: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 35. France: Intradermal Injections Market
Table 36. France: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 37. UK: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 38. UK: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 39. UK: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 40. UK: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 41. UK: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 46. Italy: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 51. Spain: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Europe: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Europe: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 56. Rest of Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 57. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million).
Table 58. Asia Pacific: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 59. Asia Pacific: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 60. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 61. Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 62. Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 63. Japan: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 64. Japan: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 65. Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 66. Japan: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 67. China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 68. China: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 69. China: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 70. China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 71. China: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 72. India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 73. India: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 74. India: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 75. India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 76. India: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 77. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 78. South Korea: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 79. South Korea: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 80. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 81. South Korea: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 82. Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 83. Australia: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 84. Australia: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 85. Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 86. Australia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 87. Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 88. Rest of Asia Pacific: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Asia Pacific: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 91. Rest of Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 92. Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 93. Middle East & Africa: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 94. Middle East & Africa: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 95. Middle East & Africa: Intradermal Injection Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 96. Middle East & Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 97. UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 98. UAE: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 99. UAE: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 100. UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 101. UAE: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 102. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 103. Saudi Arabia: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 104. Saudi Arabia: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 105. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 106. Saudi Arabia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 107. South Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 108. South Africa: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 109. South Africa: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 110. South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 111. South Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 112. Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 113. Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 114. Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 115. Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 116. Rest of Middle East and Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 117. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 118. South and Central America: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 119. South and Central America: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 120. South and Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 121. South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 122. Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 123. Argentina: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 124. Argentina: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 125. Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 126. Argentina: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 127. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 128. Brazil: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 129. Brazil: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 130. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 131. Brazil: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 132. Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 133. Rest of South & Central America: Intradermal Injections Market, by Short Needles - Revenue and Forecast to 2028 (US$ Million)
Table 134. Rest of South & Central America: Intradermal Injections Market, by Without Needles - Revenue and Forecast to 2028 (US$ Million)
Table 135. Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 136. Rest of South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 137. Developments Done by Companies
Table 138. Glossary of Terms

List Of Figures

Figure 1. Intradermal Injections Market Segmentation
Figure 2. Intradermal Injections Market, By Region
Figure 3. Global Intradermal Injections Market Overview
Figure 4. Normal Sized Needles Segment by Method Held Largest Share of Intradermal Injection Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Intradermal Injections Market, by Geography (US$ Million)
Figure 7. Global Intradermal Injections Market- Leading Country Markets (US$ Million)
Figure 8. North America PEST Analysis
Figure 9. Europe PEST Analysis
Figure 10. Asia-Pacific PEST Analysis
Figure 11. Middle East and Africa PEST Analysis
Figure 12. South and Central America PEST Analysis
Figure 13. Intradermal Injection Market Impact Analysis of Drivers and Restraints
Figure 14. Global Intradermal Injections Market- Revenue Forecast and Analysis - 2021 - 2028
Figure 15. Global Intradermal Injections Market - Revenue Forecast and Analysis - 2020- 2028
Figure 16. Market Positioning of Key Players in Global Intradermal Injections Market
Figure 17. Global Intradermal Injections Market, by Method, 2021 & 2028 (%)
Figure 18. Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Short Needles: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Intradermal Microinjection: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Microneedle Arrays: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Tattoo Devices: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Without Needle: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Global Intradermal Injections Market Share by Application - 2021 & 2028 (%)
Figure 27. Tuberculin Skin Test Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Allergy Testing Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Local Aesthetic Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Others Intradermal Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Global Intradermal Injections Market, by End User, 2021 & 2028 (%)
Figure 32. Hospital : Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Diagnostic Laboratories : Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Academic & Research Institutes : Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Others: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. North America: Intradermal Injections Market, by Key Country - Revenue (2021) (US$ Million)
Figure 37. North America Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America: Intradermal Injections Market, by Country, 2021 & 2028 (%)
Figure 39. US: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Canada: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Mexico: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Europe: Intradermal Injections Market, by Key Country - Revenue (2021) (US$ Million)
Figure 43. Europe: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
Figure 44. Europe: Intradermal Injections Market, by Country, 2021 & 2028 (%)
Figure 45. Germany: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. France: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. UK: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Italy: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Spain: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Rest of Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Asia Pacific Intradermal Injections Market Overview, by Country (2021)
Figure 52. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 53. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
Figure 54. Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 56. India: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 58. Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
Figure 60. Middle East & Africa Intradermal Injections Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 61. Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 62. Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
Figure 63. UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 64. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 65. South Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 66. Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. South and Central America Intradermal Injections Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 68. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 69. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
Figure 70. Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 71. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
Figure 72. Rest of South and Central America: Intradermal Injections Market- Revenue and Forecast to 2028 (US$ Million)
Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
Figure 74. Impact of COVID-19 Pandemic in European Country Markets
Figure 75. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 76. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 77. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

Product Code: TIPRE00019998

The intradermal injection market is projected to reach US$ 7,415.70 million by 2028 from US$ 3,513.26 million in 2021 and is expected to register a CAGR of 11.3% from 2021 to 2028.

The report highlights trends prevailing in the market and factors driving the market growth. The intradermal injection market growth is attributed to the increasing intradermal vaccination, increasing incidence of various diseases, and rising acceptance of aesthetic procedures. Additionally, stratageic developments by manufacturers are likely to emerge as a significant trend in the market during the forecast period. However, the risks, complications, and dosing limitations associated with Intradermal Injections hamper the growth of the intradermal injection market.

Most of the developing and developed countries are currently considering the healthcare sector as one of the essential segments, which resulted in the exponential increase in healthcare expenditure with the aim of providing better infrastructure and medical facilities. For fulfilling the rising global demand, various pharmaceutical giants are working to develop ideal drugs and devices, and intradermal injections are emerging as one of the potential devices used for the treatment, diagnosis, vaccination, and cosmetic procedures. Rising acceptance of intradermal vaccination is believed to act as major driver for the global intradermal injection market as it has several advantages over the conventional method of vaccination. Intradermal vaccination helps in reducing the potential dose of antigens, improves the immune response generated by the vaccine and decrease the anxiety associated with the vaccination. By developing intradermal injection, a large population can be vaccinated with comparatively lesser production of the vaccine while this method is also able to vaccinate the difficult group of population with comorbidities as chances of adverse events is low as compared to conventional vaccination. Recently, several intradermal COVID19 vaccines, hepatitis A vaccine, hepatitis B vaccine, Influenza vaccines, polio vaccine measles vaccine, Rabies vaccine, tetanus vaccine, yellow fever vaccine, diphtheria-tetanus-pertussis vaccine etc. shows improvement in the overall response rate and hence several leading pharmaceutical and biotechnological companies are currently working on the development of intradermal injections of the new as well as commercially available vaccines. In 2020, Sanofi received the FDA approval for its intradermal vaccine of Influenza names Fluzone, which is rapidly overtaking the influenza vaccine market and replacing the congenital treatments for these diseases.

Further, more than one-third of the global population has a risk of developing tuberculosis, and an intense increase in the number of tuberculosis skin test procedures has been observed during the past few years. Intradermal tuberculin syringes are used for diagnosing tuberculosis, and several leading manufacturers of drug delivery devices are currently developing these tuberculin syringes. Along with this, the prevalence of allergies has increased several times during the past decade, mainly due to the rise in awareness among the population about several allergy-related conditions. The intradermal injections are used as an ideal device for conducting sensitivity tests for several allergens.

In addition to this, the local aesthetic procedures are also increasing rapidly, and the number of nonsurgical cosmetic procedures has increased by 51.4% from 2011 to 2017 as per the estimates of ISAPS. Along with this, many new intradermal vaccinations are believed to get approval as intradermal vaccination is able to produce better response along with reduction in the required dose and adverse events. . Along with this, several studies concluded that the intradermal injection could improve the uptake of various cancers and immunological drugs while it can also be used to deliver the gene therapies. Further, continuously increasing cases of COVID19 is also indicating towards the future potential of this segment as various intradermal preparations are under investigation and about to get approved in near future. As the global population is increasing continuously, the number of cases will also increase in near future, which ultimately increases the demand of intradermal injection. Further, the novel intradermal injection devices such as Tropis ID of Pharmajet shows prominent results in delivering various drugs for targeting a wide range of diseases and expands the therapeutic area of the intradermal products.

Besides the benefits of intradermal injection, several drawbacks are also associated with these drug delivery devices including injection site reactions and dosing limitations, which are acting as major restraints for the intradermal injection market. It is observed that skin discoloration, swelling, redness, itching and irritation occurs at the site of injection after the intradermal delivery of active ingredient. For overcoming the challenges related to the injection site infections, the researchers are working to identify ideal site for injecting the drug depending upon the nature of drug and required action.

During the past few years, intradermal injections associated procedures and devices have undergone continuous innovations, and several novel technologies are incorporated in this segment for the advancement of this sector. The vaccination and diagnosis rates related to several complications have increased exponentially during the last decade, ultimately increasing the acceptance of intradermal injections.

Several organic and inorganic strategies are adopted by companies in the intradermal injection market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the intradermal injection market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and augment their geographic presence, thereby contributing to the overall growth of intradermal injection market. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few of the noteworthy developments by key players in the intradermal injection market are listed below.

In November 2021, NanoPass Technologies and Aesthetic Management Partners entered into an agreement to initiate the commercialization of NanoPass's MicronJet 600 intradermal delivery device in the US.

In August 2021, PharmaJet and Zydus Cadila received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world's first Plasmid DNA Vaccine for COVID-19. The vaccine, ZyCoV-D, is solely administered utilizing the PharmaJet Tropis Needle-free Injection System.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Health and Wellness are among the primary and secondary sources referred while preparing the report on the intradermal injection market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Intradermal Injection market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global Intradermal Injection market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distributions.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Intradermal Injections Market - By Method
- 1.3.2 Global Intradermal Injections Market - By Application
- 1.3.3 Global Intradermal Injections Market - By End User
- 1.3.4 Global Intradermal Injections Market - By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Intradermal Injections Market Landscape

4.1 Overview
4.2 PEST ANALYSIS
- 4.2.1 North America - PEST Analysis
- 4.2.2 Europe - PEST Analysis
- 4.2.3 Asia-Pacific - PEST Analysis
- 4.2.4 Middle East and Africa - PEST Analysis
- 4.2.5 South and Central America - PEST Analysis
4.3 EXPERT OPINIONS

5. Intradermal Injections Market - Key Market Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing Intradermal Vaccination
- 5.1.2 Increasing Incidences of diseases
- 5.1.3 Rising Acceptance of Aesthetic Procedures
5.2 Key Market Restraints
- 5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections
5.3 Key Market Opportunities
- 5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries
5.4 Future Trends
- 5.4.1 Strategic Developments by Manufacturers
5.5 Impact Analysis of Drivers And Restraints

6. Intradermal Injections Market- Global Analysis

6.1 Global Intradermal Injections Market Revenue Forecast and Analysis
6.2 Global Intradermal Injections Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Global Intradermal Injections Market Revenue And Forecasts To 2028- By Method

7.1 Overview
7.2 Global Intradermal Injections Market, By Method, 2021 & 2028 (%)
7.3 Normal-Sized Needles (MANTOUX)
- 7.3.1 Overview
- 7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)
7.4 Short Needles
- 7.4.1 Overview
- 7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 Intradermal Microinjection
  - 7.4.3.1 Overview
  - 7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 Microneedle Arrays
  - 7.4.4.1 Overview
  - 7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.4.5 Tattoo Devices
  - 7.4.5.1 Overview
  - 7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
7.5 Without Needles
- 7.5.1 Overview
- 7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.5.3 Intradermal Liquid Jet Injectors
  - 7.5.3.1 Overview
  - 7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)
- 7.5.4 Ballistic Intradermal Injectors
  - 7.5.4.1 Overview
  - 7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

8. Intradermal Injections Market Revenue and Forecasts To 2028 - Application

8.1 Overview
8.2 Global Intradermal Injections Market Share by Application - 2021 & 2028 (%)
8.3 Tuberculin Skin Testing
- 8.3.1 Overview
- 8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Allergy Testing
- 8.4.1 Overview
- 8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)
8.5 Local Aesthetics
- 8.5.1 Overview
- 8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)
8.6 OTHERS
- 8.6.1 Overview
- 8.6.2 Others Market Forecast and Analysis

9. Intradermal Injections Market Analysis - End User

9.1 Overview
9.2 Global Intradermal Injections Market, By End User, 2021 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
- 9.5.1 Overview
- 9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
9.6 OTHERS
- 9.6.1 Overview
- 9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

10. Intradermal Injections Market Revenue And Forecasts To 2028 - Geographical Analysis

10.1 North America: Intradermal Injections Market
- 10.1.1 Overview
- 10.1.2 North America: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.3 North America: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
  - 10.1.3.1 North America: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
  - 10.1.3.2 North America: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
- 10.1.4 North America: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
- 10.1.5 North America: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
- 10.1.6 North America: Intradermal Injections Market, by Country, 2021 & 2028 (%)
  - 10.1.6.1 US: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.1.1 Overview
    - 10.1.6.1.2 US: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.1.3 US: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
    - 10.1.6.1.3.1 US: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.6.1.3.2 US: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.6.1.4 US: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
    - 10.1.6.1.5 US: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
  - 10.1.6.2 Canada: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.2.1 Overview
    - 10.1.6.2.2 Canada: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.2.3 Canada: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
    - 10.1.6.2.3.1 Canada: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.6.2.3.2 Canada: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.6.2.4 Canada: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
    - 10.1.6.2.5 Canada: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
  - 10.1.6.3 Mexico: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.3.1 Overview
    - 10.1.6.3.2 Mexico: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.6.3.3 Mexico: Intradermal Injections Market, by Method, 2019-2028 (US$ Million)
    - 10.1.6.3.3.1 Mexico: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.1.6.3.3.2 Mexico: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.1.6.3.4 Mexico: Intradermal Injections Market, by Application, 2019-2028 (US$ Million)
    - 10.1.6.3.5 Mexico: Intradermal Injections Market, by End User, 2019-2028 (US$ Million)
10.2 Europe: Intradermal Injections Market
- 10.2.1 Overview
- 10.2.2 Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
- 10.2.3 Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
  - 10.2.3.1 Europe: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
  - 10.2.3.2 Europe: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
- 10.2.4 Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
- 10.2.5 Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 10.2.6 Europe: Intradermal Injections Market, by Country, 2021 & 2028 (%)
  - 10.2.6.1 Germany: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.1 Overview
    - 10.2.6.1.2 Germany: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.3 Germany: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.3.1 Germany: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.2.6.1.3.2 Germany: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.2.6.1.4 Germany: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.1.5 Germany: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.2.6.2 France: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.1 Overview
    - 10.2.6.2.2 France: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.3 France: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.3.1 France: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.2.6.2.3.2 France: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.2.6.2.4 France: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.2.5 France: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.2.6.3 UK: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.1 Overview
    - 10.2.6.3.2 UK: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.3 UK: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.3.1 UK: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.2.6.3.3.2 UK: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.2.6.3.4 UK: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.3.5 UK: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.2.6.4 Italy: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.1 Overview
    - 10.2.6.4.2 Italy: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.3 Italy: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.3.1 Italy: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.2.6.4.3.2 Italy: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.2.6.4.4 Italy: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.4.5 Italy: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.2.6.5 Spain: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.1 Overview
    - 10.2.6.5.2 Spain: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.3 Spain: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.3.1 Spain: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.2.6.5.3.2 Spain: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.2.6.5.4 Spain: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.5.5 Spain: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.2.6.6 Rest of Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.1 Overview
    - 10.2.6.6.2 Rest of Europe: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.3 Rest of Europe: Intradermal Injections Market, by Method - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.3.1 Rest of Europe: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.2.6.6.3.2 Rest of Europe: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.2.6.6.4 Rest of Europe: Intradermal Injections Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.2.6.6.5 Rest of Europe: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific Intradermal Injections Market Revenue and Forecasts To 2028
- 10.3.1 Overview
- 10.3.2 Asia Pacific Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
- 10.3.3 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  - 10.3.3.1 Asia Pacific: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
  - 10.3.3.2 Asia Pacific: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
- 10.3.4 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
- 10.3.5 Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 10.3.6 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  - 10.3.6.1 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.1.1 Overview
    - 10.3.6.1.2 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.1.3 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.3.6.1.3.1 Japan: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.3.6.1.3.2 Japan: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.3.6.1.4 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.1.5 Japan: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.3.6.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.2.1 Overview
    - 10.3.6.2.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.2.3 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.3.6.2.3.1 China: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.3.6.2.3.2 China: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.3.6.2.4 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.2.5 China: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.3.6.3 India Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.3.1 Overview
    - 10.3.6.3.2 India: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.3.3 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.3.6.3.3.1 India: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.3.6.3.3.2 India: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.3.6.3.4 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.3.5 India: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.3.6.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.4.1 Overview
    - 10.3.6.4.2 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.4.3 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.3.6.4.3.1 South Korea: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.3.6.4.3.2 South Korea: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.3.6.4.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.4.5 South Korea: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.3.6.5 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.5.1 Overview
    - 10.3.6.5.2 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.3.6.5.3 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.3.6.5.3.1 Australia: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.3.6.5.3.2 Australia: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.3.6.5.4 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.5.5 Australia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.3.6.6 Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.1 Overview
    - 10.3.6.6.2 Rest of Asia Pacific: Intradermal Injections Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.3.6.6.3 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.3.6.6.3.1 Rest of Asia Pacific: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.3.6.6.3.2 Rest of Asia Pacific: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.3.6.6.4 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
    - 10.3.6.6.5 Rest of Asia Pacific: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.4 Middle East & Africa Intradermal Injections Market Revenue and Forecasts To 2028
- 10.4.1 Overview
- 10.4.2 Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
- 10.4.3 Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  - 10.4.3.1 Middle East & Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
  - 10.4.3.2 Middle East & Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
- 10.4.4 Middle East & Africa: Intradermal Injection Market Revenue and Forecasts to 2028, By Application (US$ Million)
- 10.4.5 Middle East & Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 10.4.6 Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  - 10.4.6.1 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.4.6.1.1 Overview
    - 10.4.6.1.2 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.4.6.1.3 UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.4.6.1.3.1 UAE: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.4.6.1.3.2 UAE: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.4.6.1.4 UAE: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.4.6.1.5 UAE: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.4.6.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.4.6.2.1 Overview
    - 10.4.6.2.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.4.6.2.3 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.4.6.2.3.1 Saudi Arabia: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.4.6.2.3.2 Saudi Arabia: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.4.6.2.4 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.4.6.2.5 Saudi Arabia: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.4.6.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.4.6.3.1 Overview
    - 10.4.6.3.2 South Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.4.6.3.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.4.6.3.3.1 South Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.4.6.3.3.2 South Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.4.6.3.4 South Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.4.6.3.5 South Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.4.6.4 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.4.6.4.1 Overview
    - 10.4.6.4.2 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.4.6.4.3 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.4.6.4.3.1 Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.4.6.4.3.2 Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.4.6.4.4 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.4.6.4.5 Rest of Middle East and Africa: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.5 South And Central America Intradermal Injections Market Revenue and Forecasts To 2028
- 10.5.1 Overview
- 10.5.2 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
- 10.5.3 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
  - 10.5.3.1 South and Central America: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
  - 10.5.3.2 South and Central America: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
- 10.5.4 South and Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)
- 10.5.5 South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- 10.5.6 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)
  - 10.5.6.1 Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.5.6.1.1 Overview
    - 10.5.6.1.2 Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.5.6.1.3 Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.5.6.1.3.1 Argentina: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.5.6.1.3.2 Argentina: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.5.6.1.4 Argentina: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.5.6.1.5 Argentina: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.5.6.2 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.5.6.2.1 Overview
    - 10.5.6.2.2 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)
    - 10.5.6.2.3 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.5.6.2.3.1 Brazil: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.5.6.2.3.2 Brazil: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.5.6.2.4 Brazil: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.5.6.2.5 Brazil: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 10.5.6.3 Rest of South and Central America: Intradermal Injections Market- Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.3.1 Overview
    - 10.5.6.3.2 Rest of South and Central America: Intradermal Injections Market- Revenue and Forecast to 2028 (US$ Million)
    - 10.5.6.3.3 Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)
    - 10.5.6.3.3.1 Rest of South & Central America: Intradermal Injections Market, by Short Needles, 2019-2028 (US$ Million)
    - 10.5.6.3.3.2 Rest of South & Central America: Intradermal Injections Market, by Without Needles, 2019-2028 (US$ Million)
    - 10.5.6.3.4 Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)
    - 10.5.6.3.5 Rest of South and Central America: Intradermal Injections Market, by End User - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic On Intradermal Injections Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Intradermal Injections Market-Industry Landscape

12.1 Overview
12.2 Developments
- 12.2.1 Overview

13. Company Profiles

13.1 BD
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 West Pharmaceutical Services, Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Terumo Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 NanoPass
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Pharmajet
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Idevax
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 EUNSUNG GLOBAL
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Crossject
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Cardinal Health Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Hindustan Syringes and Medical Devices Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms

皮内注射市場の2028年までの予測-方法、アプリケーション、エンドユーザー別の世界分析

Intradermal injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method, Application, and End User

目次

第1章イントロダクション

第2章重要なポイント

第3章調査手法

第4章皮内注射の市場情勢

第5章皮内注射市場- 主な市場力学

第6章皮内注射の世界市場-分析

第7章：皮内注射の世界市場収益と2028年までの予測-方法別

第8章皮内注射の世界市場収益と2028年までの予測- アプリケーション編

第9章皮内注射の市場分析～エンドユーザー編

第10章皮内注射市場の収益と2028年までの予測-地域別分析

第11章 COVID-19パンデミックが皮内注射市場に与える影響

第12章皮内注射の市場-業界情勢

第13章企業プロファイル

第14章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Key Takeaways

3. Research Methodology

4. Intradermal Injections Market Landscape

5. Intradermal Injections Market - Key Market Dynamics

6. Intradermal Injections Market- Global Analysis

7. Global Intradermal Injections Market Revenue And Forecasts To 2028- By Method

8. Intradermal Injections Market Revenue and Forecasts To 2028 - Application

9. Intradermal Injections Market Analysis - End User

10. Intradermal Injections Market Revenue And Forecasts To 2028 - Geographical Analysis

11. Impact Of COVID-19 Pandemic On Intradermal Injections Market

12. Intradermal Injections Market-Industry Landscape

13. Company Profiles

14. Appendix

皮内注射市場の2028年までの予測-方法、アプリケーション、エンドユーザー別の世界分析

Intradermal injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method, Application, and End User

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

第4章 皮内注射の市場情勢

第5章 皮内注射市場- 主な市場力学

第6章 皮内注射の世界市場-分析

第7章：皮内注射の世界市場収益と2028年までの予測-方法別

第8章 皮内注射の世界市場収益と2028年までの予測- アプリケーション編

第9章 皮内注射の市場分析～エンドユーザー編

第10章 皮内注射市場の収益と2028年までの予測-地域別分析

第11章 COVID-19パンデミックが皮内注射市場に与える影響

第12章 皮内注射の市場-業界情勢

第13章 企業プロファイル

第14章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Key Takeaways

3. Research Methodology

4. Intradermal Injections Market Landscape

5. Intradermal Injections Market - Key Market Dynamics

6. Intradermal Injections Market- Global Analysis

7. Global Intradermal Injections Market Revenue And Forecasts To 2028- By Method

8. Intradermal Injections Market Revenue and Forecasts To 2028 - Application

9. Intradermal Injections Market Analysis - End User

10. Intradermal Injections Market Revenue And Forecasts To 2028 - Geographical Analysis

11. Impact Of COVID-19 Pandemic On Intradermal Injections Market

12. Intradermal Injections Market-Industry Landscape

13. Company Profiles

14. Appendix

第1章イントロダクション

第2章重要なポイント

第3章調査手法

第4章皮内注射の市場情勢

第5章皮内注射市場- 主な市場力学

第6章皮内注射の世界市場-分析

第8章皮内注射の世界市場収益と2028年までの予測- アプリケーション編

第9章皮内注射の市場分析～エンドユーザー編

第10章皮内注射市場の収益と2028年までの予測-地域別分析

第12章皮内注射の市場-業界情勢

第13章企業プロファイル

第14章付録